Literature DB >> 3318001

Carotid restenosis: long-term noninvasive follow-up after carotid endarterectomy.

R D DeGroote1, T G Lynch, Z Jamil, R W Hobson.   

Abstract

Recurrent stenosis has not been a primary consideration in the selection of patients for carotid endarterectomy. We have studied the incidence of postoperative restenosis retrospectively in 265 patients following 310 carotid endarterectomies. Two hundred fourteen patients (248 endarterectomies) were examined at 6-12 month intervals using ocular pneumoplethysmography, spectral analysis, and B-mode imaging. The absolute incidence of recurrent carotid disease was 28% (69 of 248), with a 13% (33 of 248) incidence of hemodynamically significant restenosis and a 15% (36 of 248) incidence of hemodynamically insignificant disease. Life table analysis of the data projected a 32% incidence of hemodynamically significant restenosis after 7 years and a 40% incidence of hemodynamically insignificant recurrence. These data demonstrate a progressively increasing rate of restenosis. The incidence of ipsilateral neurologic events was 8% (24 of 310); 12 occurred in association with noninvasively evident recurrent disease (12 of 69, 17%), whereas 11 occurred in noninvasively determined normal arteries (11 of 179, 6%). Noninvasive follow-up was not available in 1 patient. Of the 12 events associated with recurrent disease, 5 occurred in association with hemodynamically significant restenosis (5 of 33, 15%), whereas 7 occurred in association with hemodynamically insignificant disease (7 of 36, 19%). Carotid endarterectomy is a durable operative procedure with 92% (286 of 310) of arteries remaining asymptomatic over the period of clinical follow-up. However, absolute and life table projections of the incidence of asymptomatic restenosis are high, and this factor should be considered in the selection of patients for carotid endarterectomy, particularly in the absence of lateralizing symptoms.

Entities:  

Mesh:

Year:  1987        PMID: 3318001     DOI: 10.1161/01.str.18.6.1031

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Carotid Artery Occlusive Disease.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

2.  Does carotid restenosis predict an increased risk of late symptoms, stroke, or death?

Authors:  E F Bernstein; S Torem; R B Dilley
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

Review 3.  Management of extracranial carotid artery disease.

Authors:  Yinn Cher Ooi; Nestor R Gonzalez
Journal:  Cardiol Clin       Date:  2015-02       Impact factor: 2.213

4.  In stent restenosis predictors after carotid artery stenting.

Authors:  Mirco Cosottini; Maria Chiara Michelassi; Walter Bencivelli; Guido Lazzarotti; Silvia Picchietti; Giovanni Orlandi; Giuliano Parenti; Michele Puglioli
Journal:  Stroke Res Treat       Date:  2010-03-14

5.  Impact of completion angiography on operative conduct and results of carotid endarterectomy.

Authors:  M C Donaldson; B L Ivarsson; J A Mannick; A D Whittemore
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

6.  Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial.

Authors:  Brajesh K Lal; Kirk W Beach; Gary S Roubin; Helmi L Lutsep; Wesley S Moore; Mahmoud B Malas; David Chiu; Nicole R Gonzales; J Lee Burke; Michael Rinaldi; James R Elmore; Fred A Weaver; Craig R Narins; Malcolm Foster; Kim J Hodgson; Alexander D Shepard; James F Meschia; Robert O Bergelin; Jenifer H Voeks; George Howard; Thomas G Brott
Journal:  Lancet Neurol       Date:  2012-08-02       Impact factor: 44.182

7.  Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial.

Authors:  Leo H Bonati; Jörg Ederle; Dominick J H McCabe; Joanna Dobson; Roland L Featherstone; Peter A Gaines; Jonathan D Beard; Graham S Venables; Hugh S Markus; Andrew Clifton; Peter Sandercock; Martin M Brown
Journal:  Lancet Neurol       Date:  2009-08-28       Impact factor: 44.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.